Documents / Official release

AAWSAP DIRD, Biosensors and BioMEMS: A Survey of the Present Field, March 2010

U.S. Department of War · 2010-03-31 · 45 pages · text from the file's own layer

This Defense Intelligence Reference Document, dated 31 March 2010 and numbered DIA-08-1003-020, was prepared by the Defense Intelligence Agency's Defense Warning Office under its Advanced Aerospace Weapon System Applications Program. It surveys biosensors and biomedical microelectromechanical systems, covering brain-implanted micromachine neuroelectrodes, drug-delivery pumps, glucose sensors, neural interfaces, retinal prostheses, microfluidic lab chips, NASA cell-culture systems and microcantilever sensors. It concludes that the field is expanding rapidly, with nanomechanical systems expected to follow.

From the source:Release of 2026-09-18 Incident: 3/31/10, Las Vegas, Nevada. Released with redactions. This document is a Defense Intelligence Reference Document (DIRD), a technical reference format used by the Defense Intelligence Agency (DIA) to capture baseline knowledge on a specific topic for later analytic use. DIRDs are best understood as reference and synthesis products rather than as original research. It is one of 38 DIRDs produced under the Advanced Aerospace Weapon System Applications Program (AAWSAP) between 2009 and 2011. Because AAWSAP’s scope permitted a broad range of supporting topics, not every DIRD in the series directly concerns aerospace systems or future threat assessment. The following summary reflects the DIRD’s scope and framing at the time of writing and should not be read as implying current validation of the concepts discussed. This DIRD surveys biosensors and BioMEMS, a broad class of miniature biomedical devices that combine microscale engineering with sensing, fluid handling, stimulation, or drug-delivery functions. The report reviews major application areas including implantable blood-chemistry sensors, neural interfaces, neurostimulation, drug-delivery pumps, microfluidic systems, and emerging nanoscale extensions of the field, while emphasizing that miniaturization can improve sensitivity and enable functions that are difficult or impossible at larger scales. However, it also makes clear that practical development is constrained by biocompatibility, long-term stability, sensor drift, device degradation inside the body, and the high regulatory burden associated with implantable medical systems. The document presents BioMEMS as a rapidly growing and productive field whose future advances are likely to come through continued improvements in fabrication, materials, and reliability.

UNCLASSIFIED/ /P'OR: OP'P'l@IAL WS& 0Nk¥
Figure 23. A MEMS Microelectrode Array Implanted Into the Cortex of a Rat Brain. The lead wires from the
device can be seen . (NeuroNexus Inc.)
RETINAL DEVICES USING BIOMEMS
An example of MEMS being used in conjunction with wireless implantable systems is the
retinal implant.
These devices attempt to augment vision where it has failed due to problems such as
macular degeneration and retinitis pigmentosa. The basic idea is to use a miniature
video camera and connect it to an electrode array in the eye such that the scene in
view is converted to electrical impulses used to stimulate the sensation of sight by
direct stimulation of the receptors in the eye. Figure 24 shows this idea.
Figure 25 shows a microelectrode array that has been manufactured on a polymer
substrate such that it is exceedingly thin and flexible. The flexibility is needed so that it
conforms to the curved shape of the back of the eye. The electrode pads seen are
attached by a flexible cable.
UNCLASSIFIED/ {FOR OFFICIO! !PEii QDlk¥
27

Not linked to a story yet.

About this file

Official release, from the pursue collection. The PDF is mirrored here; the original link is above. 45 pages are in the text index: search them above, or from the library's search.